Bio-Techne
TECH
#1437
Rank
NZ$20.07 B
Marketcap
$126.56
Share price
-2.56%
Change (1 day)
5.94%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total debt

Total debt on the balance sheet as of June 2024 : NZ$0.67 B

According to Bio-Techne's latest financial reports the company's total debt is NZ$0.67 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Bio-Techne - Total debt on balance sheet (from 1999 to 2024)

Total debt by year

Year Total debt Change
2023-06-30NZ$0.74 B42.32%
2022-06-30NZ$0.52 B-13.45%
2021-06-30NZ$0.60 B-10.46%
2020-06-30NZ$0.67 B-10.51%
2019-06-30NZ$0.75 B50.12%
2018-06-30NZ$0.50 B6.61%
2017-06-30NZ$0.46 B250.22%
2016-06-30NZ$0.13 B19.69%
2015-06-30NZ$0.11 B659.49%
2014-06-30NZ$14.74 M
2006-06-30NZ$22.16 M6.05%
2005-06-30NZ$20.9 M-16.87%
2004-06-30NZ$25.14 M-14.32%
2003-06-30NZ$29.34 M-20.98%
2002-06-30NZ$37.14 M-20.26%
2001-06-30NZ$46.57 M10.75%
2000-06-30NZ$42.05 M

Total debt for similar companies or competitors

Company Total debt differencediff. Country
NZ$57.22 B 8,339.04%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.25 B 231.95%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$31.23 B 4,505.78%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$27.49 B 3,954.46%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.26 B 234.09%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
NZ$31.79 B 4,589.21%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$11.73 M-98.27%๐Ÿ‡บ๐Ÿ‡ธ USA